Supernus Pharmaceuticals Inc.
SUPN | NASDAQ
$42.78
+$0.78 (+1.86%)
At close: Sep 21, 2026, 4:00 PM ET
$43.28
+$0.50 (+1.17%)
Pre-market:
Sep 22, 2026, 8:47 AM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -58.37M | -2.29M | -38.55M | -45.12M | 22.5M | -11.83M | 15.33M | 38.5M | 19.92M | 124K | 1.18M | -15.98M | -831K | 16.95M | 25.48M | 1.75M | 7.87M | 25.62M | 2.44M | 21.56M | 23.73M | 5.69M |
Depreciation & Amortization | 25.73M | 26.14M | 92.18M | 24.81M | 21.36M | 20.38M | 18.85M | 20.09M | 20.72M | 20.75M | 21.68M | 21.86M | 20.73M | 20.6M | 20.85M | 21.78M | 21.56M | 21.36M | 12.71M | 6.68M | 6.62M | 6.59M |
Stock-Based Compensation | 8.64M | 8.48M | 33.05M | 7.83M | 7.51M | 8.07M | 7.63M | 7.67M | 6.55M | 5.9M | 6.45M | 7.92M | 6.09M | 6.31M | 4.26M | 4.99M | 4.3M | 4.03M | 4.04M | 4.03M | 5.48M | 4.37M |
Other Working Capital | 30.78M | 16.19M | -30.27M | -7.6M | 8.28M | 8.8M | -11.23M | -7.75M | 8.62M | 5.44M | -395K | 34.05M | -27.23M | -4.15M | 2.4M | 13.94M | 6.39M | 6.42M | 3.6M | -36.9M | 27.23M | 2.18M |
Other Non-Cash Items | 38.92M | 6.73M | -20.66M | 2.67M | 2.84M | 4.06M | 7.8M | 1.61M | -544K | 3.25M | 24.15M | 1.67M | 6.9M | 288K | 1.8M | 12.33M | 1.41M | -11.97M | 5.32M | 6.64M | -4.52M | 17.18M |
Deferred Income Tax | -16.95M | 5.92M | 5.21M | -2.65M | -7.16M | -3.99M | -72K | -6.47M | -8.12M | -5.48M | -10.46M | -9.27M | -5.55M | -435K | -7.76M | -2.51M | -3.05M | -13.01M | -4.52M | 1.57M | 519K | -2.57M |
Change in Working Capital | -2.79M | 21.75M | -51.36M | -49.2M | 11.49M | 13.91M | -5.13M | -7.89M | -2.9M | 13.87M | 1.97M | 29.67M | -46.2M | 5.42M | -17.07M | -24.49M | 39.03M | -21.72M | 28.77M | -44.58M | 14.45M | 4.93M |
Operating Cash Flow | -4.81M | 66.52M | 19.86M | -61.66M | 58.54M | 30.6M | 44.41M | 53.52M | 35.62M | 38.4M | 44.96M | 35.88M | -18.87M | 49.13M | 27.56M | 13.84M | 71.12M | 4.3M | 48.76M | -4.11M | 46.27M | 36.2M |
Capital Expenditures | -568K | n/a | -427K | -129K | -455K | -327K | -213K | -200K | -64K | -248K | 36K | -150K | -159K | -278K | 861K | -147K | 576K | -851K | -40K | -44K | n/a | -1.51M |
Cash Acquisitions | n/a | n/a | -293.09M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 82.09M | n/a | n/a | -310.74M | n/a | n/a | n/a |
Purchase of Investments | -50M | -78.44M | -475.94M | -126.63M | -140.56M | -118.56M | -145.41M | -224.93M | -123.98M | -193.7M | -101.62M | n/a | n/a | n/a | -66.33M | -134.16M | -108.44M | -98.06M | -3.94M | -74.36M | -114.21M | -119.06M |
Sales Maturities Of Investments | 57.66M | 59.22M | 774.92M | 468.56M | 110.4M | 156.2M | 132.98M | 148.11M | 75.45M | 142.32M | 35.6M | 34.78M | 60.46M | 240.06M | 17.55M | 52.08M | 92.19M | 28.93M | 377.96M | 68.7M | 34.27M | 49.58M |
Other Investing Acitivies | n/a | n/a | -55.86M | -293.09M | n/a | n/a | n/a | 9K | n/a | n/a | n/a | n/a | n/a | n/a | -851K | -82.09M | n/a | n/a | 12.89M | n/a | -950K | -453K |
Investing Cash Flow | 7.09M | -19.22M | -51.31M | 48.71M | -30.61M | 37.32M | -12.64M | -77.01M | -48.59M | -51.62M | -65.98M | 34.63M | 60.3M | 239.78M | -48.77M | -82.23M | -15.68M | -69.99M | 76.13M | -5.7M | -80.89M | -71.45M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -480.86M | 78.36M | n/a | n/a | n/a | n/a | -138.32M | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -11.32M | -4.56M | -31K | -2.67M | -2.34M | -23.44M | -987K | -387K | -1K | -1.34M | -1.99M | -970K | -575K | -445K | n/a | n/a | n/a | -22.9M | n/a | 800K | n/a | n/a |
Financial Cash Flow | -7.2M | 9.12M | 8.53M | 21.07M | 935K | -21.4M | 5.89M | 3.08M | 1.66M | 1.57M | 1.09M | -230K | -478.92M | 80.17M | 2.83M | 6.46M | 2.27M | -22.03M | -136.74M | 1.32M | 2.75M | 2.25M |
Net Cash Flow | -4.92M | 56.42M | -22.92M | 8.11M | 28.86M | 46.52M | 37.66M | -20.42M | -11.31M | -11.65M | -19.93M | 70.28M | -437.49M | 369.08M | -18.37M | -61.94M | 57.71M | -87.72M | -11.85M | -8.49M | -31.87M | -33M |
Free Cash Flow | -5.38M | 66.52M | 19.43M | -61.79M | 58.08M | 30.27M | 44.19M | 53.32M | 35.56M | 38.15M | 44.99M | 35.73M | -19.03M | 48.85M | 28.43M | 13.69M | 71.7M | 3.45M | 48.72M | -4.15M | 46.27M | 34.69M |
Adj. Free Cash Flow | -14.02M | 58.04M | -13.62M | -69.62M | 50.57M | 22.2M | 36.56M | 45.65M | 29.01M | 32.26M | 38.55M | 27.81M | -25.12M | 42.54M | 24.16M | 8.71M | 67.4M | -574K | 44.69M | -8.18M | 40.8M | 30.32M |
Maintenance CapEx | -568K | n/a | n/a | n/a | -455K | -144.32K | n/a | n/a | n/a | -248K | 36K | -150K | -159K | -238.31K | 1.13M | n/a | 1.15M | -147.9K | n/a | -44K | n/a | -255.65K |
Growth CapEx | n/a | n/a | -427K | -129K | n/a | -182.68K | -213K | -200K | -64K | n/a | n/a | n/a | n/a | -39.69K | -269.78K | -147K | -576K | -703.1K | -40K | n/a | n/a | -1.25M |
Owner Earnings | -5.38M | 66.52M | 19.86M | -61.66M | 58.08M | 30.45M | 44.41M | 53.52M | 35.62M | 38.15M | 44.99M | 35.73M | -19.03M | 48.89M | 28.69M | 13.84M | 72.27M | 4.15M | 48.76M | -4.15M | 46.27M | 35.94M |
Add to Watchlist
Select watchlists to add or remove SUPN